"Dipyridamole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
| Descriptor ID |
D004176
|
| MeSH Number(s) |
D03.383.742.175
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dipyridamole".
Below are MeSH descriptors whose meaning is more specific than "Dipyridamole".
This graph shows the total number of publications written about "Dipyridamole" by people in this website by year, and whether "Dipyridamole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dipyridamole" by people in Profiles.
-
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. Int J Radiat Oncol Biol Phys. 2000 Nov 01; 48(4):1089-96.
-
Are dipyridamole (sensitive) calcium channels present in esophageal smooth muscle? Life Sci. 1997; 60(26):PL423-30.
-
Dipyridamole mediated enhanced antiproliferative activity of 10-ethyl-10-deazaaminopterin (10-EDAM) against human lung cancer cell lines. J Cell Biochem Suppl. 1996; 24:165-72.
-
A comparison of tablets with oral suspension formulation of dipyridamole in thallium myocardial imaging. J Clin Pharmacol. 1992 Jun; 32(6):546-52.